Diabetes affects more than eight percent of the Thai population, a number that is on the rise, and nearly half of these cases remain undiagnosed. In…

Dr Armin Wiesler, general manager and head of Human Pharma at Boehringer Ingelheim (Thai) Ltd., explores how the affiliate has managed to achieve…

Andrea Sambatti is the general manager of Boehringer Ingelheim (BI) Sweden and is a member of the board of directors for LIF. Sambatti discusses how…

Sweden’s comprehensive and high-quality system of electronic health records is increasingly in demand from international researchers in the machine…

Franck Puget, managing director for CSL Behring in France, discusses the blood plasma specialist’s commitment to France, building bridges with…

Against an alluring backdrop, big-name pharma brands are now starting to spend heavily on in-country manufacturing, development and shared service…

With Spain now on the road to economic recovery following the ravages of the global financial crisis, multinational pharmaceutical companies are…

Timmo Andersen, general manager of Boehringer Ingelheim in Spain, explains how the affiliate has managed to achieve market-leading growth rates, the…

Austria has long been merely a cog in the wheel of global R&D, lying in the shadows of neighboring research giants, Germany and Switzerland. Now,…

Philipp von Lattorff, country managing director of Boehringer Ingelheim’s Regional Centre Vienna (RCV) discusses the current mandate of the center…

Javier Castro of Boehringer Ingelheim (BI) Colombia has been mandated to integrate Sanofi’s animal healthcare business into BI’s operation and…

Jorge Wagner, President Director at Boehringer Ingelheim Indonesia, explains the importance of innovation within the universal healthcare coverage…